Adoptive Treatment of Advanced Hepatocellular Carcinoma With Allogeneic γδ-T Cells

NCT05628545 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped COVID1-19 pandemic

Conditions

Advanced Hepatocellular Carcinoma

Interventions

BIOLOGICAL: GDKM-100 injection

Sponsor

Guangdong GD Kongming Biotech LLC

Collaborators

[object Object]